Topics
October 2015 | Special Focus: Uveitis
Promising Pipeline for Treatment of Noninfectious Posterior Uveitis
Agents and delivery mechanisms in development may offer physicians assistance in treating this heterogeneous disorder.
Steven Yeh, MD
July 30, 2026
Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models
July 28, 2026
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending
July 27, 2026
Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India
July 24, 2026
FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
